Literature DB >> 19041051

Intramyocardial transplantation of bone marrow-derived stem cells: ultrasonic strain rate imaging in a model of hibernating myocardium.

Carsten Schneider1, Korff Krause, Kai Jaquet, Stephan Geidel, Rainer Malisius, Sigrid Boczor, Thomas Rau, Tomasz Zienkiewicz, Detlef Hennig, Karl-Heinz Kuck.   

Abstract

BACKGROUND: The aim of this study was to evaluate potential cardioprotective effects of bone marrow-derived stem cells in chronic ischemic myocardium regarding strain rate parameters during dobutamine stress echocardiography.
METHODS: An ameroid constrictor was placed around the circumflex artery in 23 pigs to induce hibernating myocardium. Pigs received autologous mesenchymal stem cells (auto MSCs), allogeneic MSC (allo MSC), autologous mononuclear cells (auto MNCs), or placebo injections into the ischemic region. During dobutamine stress echocardiography, peak systolic strain rates (SR(sys)) and systolic and postsystolic strain values (epsilon(sys), epsilon(ps)) were determined. The animals were evaluated regarding myocardial fibrosis, neovascularization, apoptosis, and myocardial beta-adrenergic receptor density.
RESULTS: The median ejection fraction was reduced in the control group compared with the auto MSC-, allo MSC-, and auto MNC-treated pigs (36.5% vs 46.0% vs 46.0% vs 41.5%; P = .001, respectively). Histopathology revealed a decreased myocardial fibrosis in auto MSC- (16.3%), allo MSC- (11.3%), and auto MNC- (16.7%) treated pigs compared with controls (31.0%; P = .004). The fibrosis and echocardiographic deformation data correlated in the posterior walls: rest peak SR(sys)r = -0.92; epsilon(sys)r = -0.86; 10 microg dobutamine stimulation peak SR(sys)r = -0.88, epsilon(sys), r = -0.87 (P = .0001).
CONCLUSION: Endocardial injection of stem cells may induce cardioprotective effects in chronic ischemic myocardium and helps to keep the ischemic myocardium viable.

Entities:  

Mesh:

Year:  2008        PMID: 19041051     DOI: 10.1016/j.cardfail.2008.08.005

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  7 in total

Review 1.  [Interventional, intramyocardial stem cell therapy in ischemic cardiomyopathy: update 2010].

Authors:  M W Bergmann; K Jaquet; C Schneider; K Krause; A Ujeyl; K-H Kuck
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

Review 2.  The role of chemokines in mesenchymal stem cell homing to myocardium.

Authors:  Yaojiong Wu; Robert C H Zhao
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

3.  A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart.

Authors:  Nicholas A Kouris; Jayne M Squirrell; Jangwook P Jung; Carolyn A Pehlke; Timothy Hacker; Kevin W Eliceiri; Brenda M Ogle
Journal:  Regen Med       Date:  2011-09       Impact factor: 3.806

Review 4.  The benefits and risks of stem cell technology.

Authors:  A Leventhal; G Chen; A Negro; M Boehm
Journal:  Oral Dis       Date:  2011-11-18       Impact factor: 3.511

5.  Adjustment and characterization of an original model of chronic ischemic heart failure in pig.

Authors:  Laurent Barandon; Joachim Calderon; Patricia Réant; Dominique Caillaud; Stéphane Lafitte; Xavier Roques; Thierry Couffinhal; Pierre Dos Santos
Journal:  Cardiol Res Pract       Date:  2010-09-07       Impact factor: 1.866

6.  Deformation imaging to assess global and regional effects of cardiac regenerative therapy in ischaemic heart disease: A systematic review.

Authors:  Bas R van Klarenbosch; Steven A J Chamuleau; Arco J Teske
Journal:  J Tissue Eng Regen Med       Date:  2019-09-01       Impact factor: 3.963

Review 7.  Potential and clinical utility of stem cells in cardiovascular disease.

Authors:  Korff Krause; Carsten Schneider; Kai Jaquet; Karl-Heinz Kuck
Journal:  Stem Cells Cloning       Date:  2010-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.